Literature DB >> 33604745

The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.

Hamizah Sa'at1, Yew-Kong Lee2, Sook-Yee Yoon3, Siu Wan Wong3, Yin Ling Woo4, Kristine Barlow-Stewart5, Nur Aishah Mohd Taib6,7.   

Abstract

The decision to have risk-reducing salpingo-oophorectomy (RRSO) by BRCA mutation carriers to reduce the risk of ovarian cancer is difficult. The choice involves trade-offs in terms of its risks and benefits. To date, understanding the decision-making needs of RRSO among Southeast Asian BRCA mutation carriers is limited. This study aimed to explore the decision-making needs of Malaysian BRCA mutation carriers as an exemplar for the Southeast Asian community. In-depth interviews and clinic observations were conducted with 31 BRCA mutation carriers and analysed thematically. The core theme identified was 'Coping with complex information and alleviating uncertainties' with the following subthemes: (1) the need for an adjustment period, (2) information support, (3) social support and, (4) religious support. We found that women required time to accept their BRCA mutation status before they were ready to make a risk-reducing choice; that understanding complex genetic information and multiple risk management options can be an overwhelming experience; and obtaining further information and a second opinion were challenging. Many described the need for experiential information from other peer-carriers who had undergone RRSO. Support from their spouse and family members was thought to be essential for them to feel reassured with their decision. Many relied on religion to positively cope with cancer risk and cancer worry; Muslim BRCA carriers sought religious guidance through prayers and Islamic fatwas to feel more certain about their RRSO decision. These findings underscore the importance of the provision of resources and support that includes input from peers, husband, family members and religion to underpin the decision-making needs of Malaysian BRCA mutation carriers considering RRSO.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Entities:  

Keywords:  BRCA mutation carriers; Medical decision-making; Risk-reducing salpingo-oophorectomy; Southeast Asia

Mesh:

Year:  2021        PMID: 33604745     DOI: 10.1007/s10689-021-00232-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  46 in total

1.  Adapting the coping in deliberation (CODE) framework: a multi-method approach in the context of familial ovarian cancer risk management.

Authors:  Jana Witt; Glyn Elwyn; Fiona Wood; Mark T Rogers; Usha Menon; Kate Brain
Journal:  Patient Educ Couns       Date:  2014-07-14

Review 2.  The state of shared decision making in Malaysia.

Authors:  Yew Kong Lee; Chirk Jenn Ng
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2017-05-18

3.  NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

Authors:  Mary B Daly; Robert Pilarski; Michael Berry; Saundra S Buys; Meagan Farmer; Susan Friedman; Judy E Garber; Noah D Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K Litton; Lisa Madlensky; Sofia D Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C Voian; Jeffrey N Weitzel; Myra J Wick; Georgia L Wiesner; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

4.  Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.

Authors:  M G Harmsen; M Arts-de Jong; K Horstik; P Manders; L F A G Massuger; R P M G Hermens; N Hoogerbrugge; G H Woldringh; J A de Hullu
Journal:  Gynecol Oncol       Date:  2016-07-16       Impact factor: 5.482

Review 5.  Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jillian T Henderson; Elizabeth M Webber; George F Sawaya
Journal:  JAMA       Date:  2018-02-13       Impact factor: 56.272

6.  Unmet support needs and distress among women with a BRCA1/2 mutation.

Authors:  Ashley Farrelly; Victoria White; Bettina Meiser; Michael Jefford; Mary-Anne Young; Sandra Ieropoli; Ingrid Winship; Jessica Duffy
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 7.  Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.

Authors:  Johanna Ringwald; Christina Wochnowski; Kristin Bosse; Katrin Elisabeth Giel; Norbert Schäffeler; Stephan Zipfel; Martin Teufel
Journal:  J Genet Couns       Date:  2016-04-14       Impact factor: 2.537

Review 8.  An overview of patient involvement in healthcare decision-making: a situational analysis of the Malaysian context.

Authors:  Chirk-Jenn Ng; Ping-Yein Lee; Yew-Kong Lee; Boon-How Chew; Julia P Engkasan; Zarina-Ismail Irmi; Nik-Sherina Hanafi; Seng-Fah Tong
Journal:  BMC Health Serv Res       Date:  2013-10-11       Impact factor: 2.655

Review 9.  Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.

Authors:  Claudia Marchetti; Francesca De Felice; Innocenza Palaia; Giorgia Perniola; Angela Musella; Daniela Musio; Ludovico Muzii; Vincenzo Tombolini; Pierluigi Benedetti Panici
Journal:  BMC Womens Health       Date:  2014-12-12       Impact factor: 2.809

10.  Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.

Authors:  Masami Arai; Shiro Yokoyama; Chie Watanabe; Reiko Yoshida; Mizuho Kita; Megumi Okawa; Akihiro Sakurai; Masayuki Sekine; Junko Yotsumoto; Hiroyuki Nomura; Yoshinori Akama; Mayuko Inuzuka; Tadashi Nomizu; Takayuki Enomoto; Seigo Nakamura
Journal:  J Hum Genet       Date:  2017-11-08       Impact factor: 3.172

View more
  1 in total

1.  Shared decision-making in Malaysia: Legislation, patient involvement, implementation and the impact of COVID-19.

Authors:  Yew Kong Lee; Chirk Jenn Ng; Ping Yein Lee; Wen Ting Tong; Hamizah Sa'at
Journal:  Z Evid Fortbild Qual Gesundhwes       Date:  2022-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.